Semaglutide API price plunges amid GLP-1 rush
Global demand for weight-loss drugs Ozempic and Wegovy has caused semaglutide prices to drop significantly. Manufacturing has expanded rapidly, and patents are expiring in key markets. Indian drugmakers are launching generics at lower prices. Experts predict further price softening in the coming months, benefiting consumers with wider access to these therapies.